Page last updated: 2024-09-05

deflazacort and Muscle Weakness

deflazacort has been researched along with Muscle Weakness in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alman, BA; Biggar, WD; Raza, SN	1
Balaban, B; Carry, T; Clayton, GH; Matthews, DJ	1
Cengiz, B; Kuruoğlu, R; Sucak, G; Tan, E	1

Trials

1 trial(s) available for deflazacort and Muscle Weakness

Article	Year
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy. The Journal of bone and joint surgery. American volume, 2004, Volume: 86, Issue:3 Topics: Activities of Daily Living; Adolescent; Anti-Inflammatory Agents; Child; Disease Progression; Follow-Up Studies; Humans; Male; Muscle Weakness; Muscular Dystrophy, Duchenne; Predictive Value of Tests; Pregnenediones; Prevalence; Proportional Hazards Models; Risk Factors; Scoliosis; Spinal Fusion; Survival Analysis; Time Factors; Treatment Outcome; Vital Capacity; Walking	2004

Article

Year

Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.

The Journal of bone and joint surgery. American volume, 2004, Volume: 86, Issue:3

Topics: Activities of Daily Living; Adolescent; Anti-Inflammatory Agents; Child; Disease Progression; Follow-Up Studies; Humans; Male; Muscle Weakness; Muscular Dystrophy, Duchenne; Predictive Value of Tests; Pregnenediones; Prevalence; Proportional Hazards Models; Risk Factors; Scoliosis; Spinal Fusion; Survival Analysis; Time Factors; Treatment Outcome; Vital Capacity; Walking

2004

Other Studies

2 other study(ies) available for deflazacort and Muscle Weakness

Article	Year
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. American journal of physical medicine & rehabilitation, 2005, Volume: 84, Issue:11 Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Motor Skills; Muscle Weakness; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Statistics, Nonparametric	2005
Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Aged; Bone Marrow; Eosinophils; Fatigue; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Leukocyte Count; Mental Disorders; Methylprednisolone; Muscle Weakness; Neural Conduction; Paraplegia; Peripheral Nervous System Diseases; Pregnenediones; Pulmonary Eosinophilia; Treatment Failure; Ventricular Dysfunction, Left	1999

Article

Year

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.

American journal of physical medicine & rehabilitation, 2005, Volume: 84, Issue:11

Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Motor Skills; Muscle Weakness; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Statistics, Nonparametric

2005

Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels.

Acta neurologica Belgica, 1999, Volume: 99, Issue:2

Topics: Aged; Bone Marrow; Eosinophils; Fatigue; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Leukocyte Count; Mental Disorders; Methylprednisolone; Muscle Weakness; Neural Conduction; Paraplegia; Peripheral Nervous System Diseases; Pregnenediones; Pulmonary Eosinophilia; Treatment Failure; Ventricular Dysfunction, Left

1999